Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China · Delayed Price · Currency is CNY 2.160
+0.010 (0.47%)
Jul 10, 2026, 3:00 PM CST
SHA:603077 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,194 | 18,021 | 16,372 | 20,591 | 26,524 | 28,624 | |
Market Cap Growth | 20.47% | 10.07% | -20.49% | -22.37% | -7.33% | 136.22% |
Enterprise Value | 19,532 | 20,375 | 17,861 | 19,320 | 24,994 | 28,461 |
Last Close Price | 2.15 | 2.26 | 2.04 | 2.34 | 2.96 | 3.30 |
PE Ratio | - | - | 520.33 | 16.05 | 6.97 | 9.48 |
Forward PE | - | 37.06 | 37.06 | 37.06 | 37.06 | 37.06 |
PS Ratio | 2.51 | 2.51 | 1.92 | 2.33 | 2.03 | 2.87 |
PB Ratio | 0.95 | 1.00 | 0.86 | 1.02 | 1.34 | 1.96 |
P/TBV Ratio | 1.27 | 1.36 | 1.14 | 1.33 | 1.75 | 2.76 |
P/FCF Ratio | - | - | - | - | 15.53 | 19.58 |
P/OCF Ratio | 14.91 | 16.74 | 34.99 | 256.33 | 10.03 | 8.75 |
EV/Sales Ratio | 2.85 | 2.84 | 2.09 | 2.19 | 1.92 | 2.85 |
EV/EBITDA Ratio | 19.23 | 23.97 | 19.31 | 8.02 | 4.63 | 6.65 |
EV/EBIT Ratio | - | - | - | 13.59 | 5.57 | 7.80 |
EV/FCF Ratio | - | - | - | - | 14.63 | 19.47 |
Debt / Equity Ratio | 0.50 | 0.49 | 0.42 | 0.10 | 0.09 | 0.09 |
Debt / EBITDA Ratio | 8.93 | 10.07 | 8.60 | 0.81 | 0.34 | 0.32 |
Debt / FCF Ratio | - | - | - | - | 1.06 | 0.94 |
Net Debt / Equity Ratio | 0.12 | 0.11 | 0.06 | -0.05 | -0.14 | -0.03 |
Net Debt / EBITDA Ratio | 2.26 | 2.37 | 1.14 | -0.45 | -0.51 | -0.09 |
Net Debt / FCF Ratio | -82.05 | -11.03 | -1.63 | 1.46 | -1.62 | -0.27 |
Asset Turnover | 0.23 | 0.25 | 0.32 | 0.36 | 0.62 | 0.61 |
Inventory Turnover | 1.41 | 1.59 | 1.79 | 2.11 | 5.01 | 7.60 |
Quick Ratio | 2.44 | 2.04 | 1.69 | 1.40 | 1.92 | 1.10 |
Current Ratio | 3.85 | 3.18 | 2.61 | 2.69 | 2.60 | 1.49 |
Return on Equity (ROE) | -2.97% | -3.86% | -0.36% | 6.40% | 22.15% | 23.33% |
Return on Assets (ROA) | 0.04% | -0.28% | -0.12% | 3.65% | 13.34% | 13.97% |
Return on Invested Capital (ROIC) | 0.09% | -0.65% | -0.26% | 6.55% | 24.44% | 23.00% |
Return on Capital Employed (ROCE) | 0.10% | -0.50% | -0.20% | 6.80% | 22.00% | 24.70% |
Earnings Yield | -2.18% | -2.98% | 0.19% | 6.23% | 14.35% | 10.54% |
FCF Yield | -0.16% | -1.01% | -3.96% | -3.64% | 6.44% | 5.11% |
Dividend Yield | - | - | 0.98% | - | 1.52% | 0.46% |
Payout Ratio | - | - | 783.94% | 36.13% | 5.20% | 2.58% |
Buyback Yield / Dilution | 11.34% | 6.13% | 2.32% | -0.10% | -3.09% | 1.10% |
Total Shareholder Return | 11.34% | 6.13% | 3.30% | -0.10% | -1.57% | 1.55% |